Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used
against HIV infections as a fixed-dose combination with another protease ...
Lopinavir | C37H48N4O5 | CID 92727 - structure, chemical names, physical and
chemical properties, classification, patents, literature, biological activities, ...
KALETRA<sup>®</sup> (lopinavir/ritonavir) is a prescription HIV-1 medicine that is used with
other HIV medicines to treat HIV-1 (Human Immunodeficiency Virus) infection in ...
Jul 9, 2015 ... Lopinavir and ritonavir (Kaletra) HIV drug treatment side effects, drug interactions
, dosage, and pregnancy safety information.
Medscape - HIV dosing for Kaletra (lopinavir/ritonavir), frequency-based adverse
effects, comprehensive interactions, contraindications, pregnancy & lactation ...
Easy to read patient leaflet for lopinavir/ritonavir. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Aug 29, 2007 ... Description. Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class
. It is marketed by Abbott as Kaletra, a co-formulation with a ...
Lopinavir is a drug used as part of antiretroviral therapy (ART). It is manufactured
by Abbvie. Lopinavir is a protease inhibitor. The amount of Lopinavir in the ...
Lopinavir and ritonavir combination is used in the treatment of the infection
caused by the human immunodeficiency virus (HIV). HIV is the virus responsible
KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. ...
KALETRA oral solution is available for oral administration as 80 mg lopinavir and